While we analyzed the targets and drugs for COVID-19 patients having multiple comorbidities, for diabetes, cancer and COVID-19, PIK3R1 was identified as the only target and there is no approved drug identified through DTP [42] search. The gene discussed is PIK3R1; the disease is cancer.